Key financial metrics and fundamentals for Supernus Pharmaceuticals, Inc. (SUPN).
Market Cap
$2.80B
P/E Ratio
-95.78
Forward P/E
--
EPS
$-0.50
Forward EPS
Dividend Yield
Beta
Revenue
52-Week Low
52-Week High